161 related articles for article (PubMed ID: 15301035)
1. Postexposure prophylaxis against varicella-zoster virus infection among recipients of hematopoietic stem cell transplant: unresolved issues.
Weinstock DM; Boeckh M; Boulad F; Eagan JA; Fraser VJ; Henderson DK; Perl TM; Yokoe D; Sepkowitz KA
Infect Control Hosp Epidemiol; 2004 Jul; 25(7):603-8. PubMed ID: 15301035
[TBL] [Abstract][Full Text] [Related]
2. Postexposure prophylaxis against varicella zoster virus infection among hematopoietic stem cell transplant recipients.
Weinstock DM; Boeckh M; Sepkowitz KA
Biol Blood Marrow Transplant; 2006 Oct; 12(10):1096-7. PubMed ID: 17084374
[No Abstract] [Full Text] [Related]
3. [Prevention and therapy of herpesvirus infections].
Abb J
Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Feb; 180(2-3):107-20. PubMed ID: 2986378
[TBL] [Abstract][Full Text] [Related]
4. Visceral varicella zoster virus (VZV) after allogeneic hematopoietic stem cell transplant (HSCT) in pediatric patients with chronic graft-versus-host disease (cGVHD).
Peritz DC; Duncan C; Kurek K; Perez-Atayde AR; Lehmann LE
J Pediatr Hematol Oncol; 2008 Dec; 30(12):931-4. PubMed ID: 19131784
[TBL] [Abstract][Full Text] [Related]
5. Prevention of VZV infection in immunosuppressed patients using antiviral agents.
Boeckh M
Herpes; 2006 Nov; 13(3):60-5. PubMed ID: 17147908
[TBL] [Abstract][Full Text] [Related]
6. [Antiviral prophylaxis].
Graubner UB
Klin Padiatr; 2001 Sep; 213 Suppl 1():A69-76. PubMed ID: 11577365
[TBL] [Abstract][Full Text] [Related]
7. Sequential Onset of Varicella-Zoster Virus Encephalomeningitis and Progressive Multifocal Leukoencephalopathy in an Allogeneic Hematopoietic Stem Cell Transplant Recipient.
Yamashita Y; Kusakabe S; Toda J; Ohshima K; Masaie H; Yagi T; Yoshida H; Ishikawa J
Exp Clin Transplant; 2018 Oct; 16(5):628-630. PubMed ID: 27938314
[TBL] [Abstract][Full Text] [Related]
8. Varicella vaccine in recipients of hematopoietic-cell transplants.
Mehta J
N Engl J Med; 2002 Nov; 347(20):1624-5; author reply 1624-5. PubMed ID: 12434769
[No Abstract] [Full Text] [Related]
9. Prophylaxis of herpesvirus infections in immunocompetent and immunocompromised older patients.
Fillet AM
Drugs Aging; 2002; 19(5):343-54. PubMed ID: 12093321
[TBL] [Abstract][Full Text] [Related]
10. The effect of low-dose aciclovir on reactivation of varicella zoster virus after allogeneic haemopoietic stem cell transplantation.
Thomson KJ; Hart DP; Banerjee L; Ward KN; Peggs KS; Mackinnon S
Bone Marrow Transplant; 2005 Jun; 35(11):1065-9. PubMed ID: 15806119
[TBL] [Abstract][Full Text] [Related]
11. Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients.
Dykewicz CA; ; ;
Clin Infect Dis; 2001 Jul; 33(2):139-44. PubMed ID: 11418871
[TBL] [Abstract][Full Text] [Related]
12. [Herpesvirus and varicella-zoster virus after bone marrow transplantation].
Milpied N
Presse Med; 1997 Jan; 26 Suppl 1():4-6. PubMed ID: 9082439
[No Abstract] [Full Text] [Related]
13. Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation.
Kanda Y; Mineishi S; Saito T; Saito A; Yamada S; Ohnishi M; Chizuka A; Niiya H; Suenaga K; Nakai K; Takeuchi T; Makimoto A; Tanosaki R; Kami M; Tanaka Y; Fujita S; Watanabe T; Kobayashi Y; Tobinai K; Takaue Y
Bone Marrow Transplant; 2001 Oct; 28(7):689-92. PubMed ID: 11704792
[TBL] [Abstract][Full Text] [Related]
14. Varicella-zoster virus infections in the immunocompromised host. Natural history and treatment.
Balfour HH
Scand J Infect Dis Suppl; 1991; 80():69-74. PubMed ID: 1666447
[TBL] [Abstract][Full Text] [Related]
15. Prevention and early treatment of opportunistic viral infections in patients with leukemia and allogeneic stem cell transplantation recipients.
Angarone M; Ison MG
J Natl Compr Canc Netw; 2008 Feb; 6(2):191-201. PubMed ID: 18319051
[TBL] [Abstract][Full Text] [Related]
16. Prevention and Management of Tuberculosis in Transplant Recipients: From Guidelines to Clinical Practice.
Muñoz L; Santin M
Transplantation; 2016 Sep; 100(9):1840-52. PubMed ID: 27306535
[TBL] [Abstract][Full Text] [Related]
17. Aciclovir and varicella-zoster-immunoglobulin in solid-organ transplant recipients.
Prelog M; Schönlaub J; Zimmerhackl LB
Pediatr Nephrol; 2011 May; 26(5):663-73. PubMed ID: 21076967
[TBL] [Abstract][Full Text] [Related]
18. Vaccinations against infectious diseases in hematopoietic stem cell transplant recipients.
Goldberg SL; Cicogna CE; Rowley SD; Pecora AL
Oncology (Williston Park); 2003 Apr; 17(4):539-54, 559; discussion 559-60, 564-5. PubMed ID: 12735146
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus in hematopoietic stem cell transplant recipients.
Ljungman P; Hakki M; Boeckh M
Infect Dis Clin North Am; 2010 Jun; 24(2):319-37. PubMed ID: 20466273
[TBL] [Abstract][Full Text] [Related]
20. Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective. Preface.
Tomblyn M; Chiller T; Einsele H; Gress R; Sepkowitz K; Storek J; Wingard JR; Young JA; Boeckh MJ
Bone Marrow Transplant; 2009 Oct; 44(8):453-5. PubMed ID: 19861977
[No Abstract] [Full Text] [Related]
[Next] [New Search]
